PNTG · Pennant Group, Inc.

Track PNTG — free

$39.32 +0.68 (+1.76%) At close · Aug 14

Market Cap

$1.37B

34.93M

Up next

Next earnings call

Nov 6, 2026 Est · unconfirmed · in 12 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Aug 5, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Ask ALVIS about this →

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Buy Momentum Strong Sentiment Bullish Fundamentals Strong Quant / Vol Moderate

Market backdrop VIX 14.3 · calm Equity put/call 0.52

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +22%

above

Price vs 50-day avg +4%

above

RSI (14) 51

neutral

MACD trend Negative

52-week position 85%

near high

Volume (OBV) Bullish div.

accumulating

Momentum

relative strength

Strong

1-month return −6%

trailing

6-month return +21%

trailing

YTD return +40%

this year

Relative strength +7%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $38 › 200d $32 — 50d above 200d

Institutional flow Accumulating

+5% holders QoQ · +40 funds added

Insider flow Distributing

Net -$218.7K over 90 days · 100% sells

Short interest Falling

1.91% of float · ▼ -8.0% MoM · 2.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

200 holders — near 3-yr high, broad support

Squeeze score 45

elevated · 0–100

Fundamentals

Strong

Revenue growth +36%

Y/Y

EPS growth +20%

Y/Y

Free cash flow $36.3M

Valuation P/E 43.2

rich

Buyback $1.0M

authorized

Balance sheet $168.8M

net debt

Quant / Vol

risk profile

Moderate

Volatility 37%

annualized · 1-yr

Max drawdown −18%

past year

ATR 3.8%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Aug 5, 2026

Total revenue · full year 2026 $1.17B – $1.19B

Adjusted earnings per diluted share · full year 2026 Non-GAAP $1.34 – $1.41

Adjusted EBITDA · full year 2026 Non-GAAP $94.4M – $98M

Adjusted EBITDA prior to NCI · full year 2026 Non-GAAP $101.5M – $105.1M

Adjusted EBITDA prior to NCI · full year 2026 Non-GAAP $20.8M – $22.5M

Revenue · full year 2026 $196M – $198M

Adjusted EBITDA · full year 2026 Non-GAAP $17M – $18.6M

Prior guidance period ended · from the 8-K filed Nov 5, 2025

Total revenue · full year 2025 $911.4M – $948.6M

Adjusted EBITDA · full year 2025 $70.9M – $73.8M

Adjusted earnings per diluted share · full year 2025 $1.14 – $1.18

Guided vs delivered · last 1 settled

Total revenue full year 2025

guided $911.4M – $948.6M

guided $911.4M – $948.6M $947.71M In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy

1 · 2 · 4

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+22% Bullish

Price vs 50-day avg

+4% Bullish

RSI (14)

51 Neutral

MACD trend

Negative Bearish

52-week position

85% Bullish

Volume (OBV)

Bullish div. Bullish

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $38 › 200d $32 — 50d above 200d

Institutional flow Accumulating

+5% holders QoQ · +40 funds added

Insider flow Distributing

Net -$218.7K over 90 days · 100% sells

Short interest Falling

1.91% of float · ▼ -8.0% MoM · 2.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

200 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $24 Now $39 · 85% Range high $42

vs 200-day avg +22% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
average monthly revenue per occupied room	$5,392	the second quarter	—

average occupancy	78.9%	the second quarter	—

Consolidated Adjusted EBITDA non-GAAP	$24.3M	the second quarter	—

Consolidated Adjusted EBITDA prior to NCI non-GAAP	$26.1M	the second quarter	—

Consolidated Adjusted EBITDAR non-GAAP	$37.6M	the second quarter	—

Home Health and Hospice Services segment adjusted EBITDA from operations non-GAAP	$37.7M	the second quarter	—

Hospice average daily census	5,477	the second quarter	—

same store average monthly revenue per occupied room	$5,413	the second quarter	—
same store average occupancy	81.6%	the second quarter	—
Senior Living segment adjusted EBITDA from operations non-GAAP	$5.8M	the second quarter	—

Total home health admissions	28,947	the second quarter	—

Total Medicare home health admissions	11,916	the second quarter	—

Adjusted net income non-GAAP	$11.5M	first quarter of 2026	—

Home Health and Hospice Services segment adjusted EBITDAR from operations non-GAAP	$36.8M	first quarter of 2026	—

Senior Living segment adjusted EBITDAR from operations non-GAAP	$16.3M	first quarter of 2026	—
Senior Living average occupancy	80.6%	fourth quarter 2025	—
Senior Living segment occupancy	79.7%	full year 2025	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Care Facilities — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
PNTG Pennant Group, Inc. this stock	$1.37B	+39.7%	+36.3%	43.2	1.9%
HCA HCA Healthcare, Inc.	$89.77B	-13.3%	+7.1%	13.9	2.7%
FSNUY Fresenius SE & Co. KGaA	$30.87B	-4.4%	—	—	0.0%
THC Tenet Healthcare Corp	$21.48B	+34.8%	+0.9%	10.3	4.0%
FMS Fresenius Medical Care AG	$12.65B	-0.2%	+5.9%	—	0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

200

% held: 89.4%
Net QoQ: +31.6K sh
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

206

View

Short & Settlement

Short Interest Falling

Shares short

667.3K

Days to cover: 2.9d
Change: -57.7K sh

View

Short Volume

Short vol %

43%

As of: Aug 14, 2026

Short Total

View

Fails to Deliver

FTD shares

4.2K

Value: $167.4K
As of: Jul 14, 2026

View

Off-Exchange

Off-exchange %

46.8%

Week of: Jul 6, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$218.7K

Buyers / Sellers: 0 / 2

Buyers Sellers

View

Financials

Revenue (FY)

$947.7M

Net income (FY): $29.6M
EPS diluted: $0.84

View

Buybacks

Authorized

$1.0M

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 5, 2026
This year: 8

View

Proposed Sales

Value

$53.7K

Shares: 1.4K
Filed: Aug 6, 2026

View

Earnings & Events

Earnings Calls

Last call

Aug 6, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
PNTG	+0.8%	-6.3%	+20.8%	-2.5%	+39.7%
SPY	+0.4%	+4.5%	+13.8%	+3.9%	+13.9%
vs SPY	+0.4%	-10.7%	+7.0%	-6.4%	+25.8%

Capital returns

Buyback program · as of Dec 12, 2022

Authorized

$1.00M

Spent (derived)

—

Remaining

—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1766400 CUSIP 70805E109 13F (30d) 197 filings 195 filers Visit website Investor relations

PNTG · Pennant Group, Inc.

Price & Indicators

Up next

AI Brief

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns